Evidence map›Paper›PMID 16085737›Full record

ReviewPostgraduate medical journal2005

Diabetes and ethnic minorities.

J Oldroyd, M Banerjee, A Heald, K Cruickshank

2 registry-linked trialsAbstract readReview
In one paragraph

Review in Postgraduate medical journal, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 57 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03196895 nacompletednot on this mapstarted 2017, after this paper: background citation

Treating Type 2 Diabetes by Reducing Postprandial Glucose Elevations: A Paradigm Shift in Lifestyle Modification

TypeinterventionalSponsorUniversity of VirginiaRan2017 to 2020Enrolled192ConditionsDiabetes Mellitus, Type 2ArmsWeight reduction training, PPG training, discrete BG feedback, continuous BG feedback
NCT03207893 nacompletednot on this mapstarted 2018, after this paper: background citation

Benefits of Adding Continuous Glucose Monitoring to Glycemic Load, Exercise, and Monitoring of Blood Glucose (GEM) for Adults With Type 2 Diabetes - Phase 2

TypeinterventionalSponsorUniversity of VirginiaRan2018 to 2020Enrolled24ConditionsDiabetes Mellitus, Type 2ArmsGEM lifestyle modification & continuous glucose monitoring, Routine Care
3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression.Movement disorders : official journal of the Movement Disorder Society · 2021
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Adolescent Immigration and Type-2 Diabetes.Current diabetes reports · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

J OldroydUniversity Department of Medicine, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK. john.oldroyd@man.ac.uk
M Banerjee
A Heald
K Cruickshank

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global prevalence of diabetes for all age groups is estimated to be 2.8%. Type 2 diabetes accounts for at least 90% of diabetes worldwide. Diabetes incidence, prevalence, and disease progression varies by ethnic group. This review highlights unique aspects of the risk of developing diabetes, its overwhelming vascular complications, and their management mainly using data among South Asians and African-Caribbeans in the UK but also using non-UK data. It is concluded that although the origin of the ethnic differences in incidence need further clarification, many factors should be amenable to prevention and treatment in all ethnic groups worldwide.

Indexed as

Chronic DiseaseDiabetes ComplicationsDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2EthnicityHealth Services AccessibilityHumansIncidencePrevalenceRisk FactorsSocioeconomic FactorsUnited Kingdom

Identifiers

PMID16085737
PMCPMC1743339

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.